Switch to
View more

Caplin Point Laboratories Ltd

CAPLIPOINT
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,414 cr, stock is ranked 458
Moderate RiskStock is 2.77x as volatile as Nifty
717.202.90 (+0.41%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,414 cr, stock is ranked 458
Moderate RiskStock is 2.77x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
18.06
PB RatioPB Ratio
4.50
Dividend YieldDiv. Yield
0.28%
Sector PESector PE
32.89
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120220.670.901.081.310.180.220.240.30
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Resignation 
Announced OnJun 25, 2022

Caplin Point Laboratories Limited has informed the Exchange about resignation of Dinesh R G as Company Secretary of the company w.e.f. 24-Jun-2022 | Download

Caplin Point Laboratories Limited has informed the Exchange about resignation of Dinesh R G as Company Secretary of the company w.e.f. 24-Jun-2022 | Download

Loss of share certificate 
Announced OnJun 17, 2022

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 | Download

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 | Download

Cash Dividend 
Ex. DateMay 23, 2022

Interim • Div/Share: ₹ 2

See all events